Abbott Laboratories (ABT)

Activity ratios

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Inventory turnover	3.01	2.93	3.10	3.33	2.97	2.95	2.94	3.05	3.04	2.95	3.36	3.46	3.74	3.58	3.60	3.85	3.73	3.54	3.39	3.44
Receivables turnover	4.22	4.21	5.78	6.06	5.85	5.94	6.11	6.11	6.15	6.52	5.08	7.02	7.03	6.33	6.20	6.64	6.61	6.58	6.12	5.40
Payables turnover	4.89	4.73	4.88	4.91	5.01	4.87	4.80	4.67	5.10	4.82	4.50	4.63	5.19	4.70	4.31	4.51	4.88	4.80	4.49	4.37
Working capital turnover	4.27	3.91	4.17	4.42	4.63	4.35	4.83	4.54	4.15	4.39	4.26	4.48	3.92	3.63	4.13	3.87	3.98	4.02	3.99	4.06

		Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Days of inventory on hand (DOH)	days	121.36	124.71	117.80	109.75	123.07	123.70	124.18	119.50	120.14	123.57	108.61	105.63	97.49	101.87	101.32	94.77	97.89	103.03	107.63	106.17
Days of sales outstanding (DSO)	days	86.57	86.63	63.16	60.25	62.44	61.43	59.78	59.74	59.36	56.00	71.87	51.99	51.94	57.69	58.87	54.97	55.26	55.46	59.59	67.65
Number of days of payables	days	74.59	77.22	74.77	74.33	72.87	74.88	75.99	78.12	71.56	75.73	81.05	78.84	70.27	77.59	84.69	81.01	74.75	76.09	81.24	83.59

	Sep 30, 2025	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Fixed asset turnover	3.81	3.78	3.87	3.94	3.88	—	—	—	4.18	4.26	4.47	4.76	5.18	5.17	5.00	4.81	4.79	4.56	4.23	3.83
Total asset turnover	0.52	0.51	0.52	0.52	0.55	0.56	0.56	0.55	0.55	0.55	0.56	0.59	0.62	0.61	0.60	0.57	0.57	0.55	0.51	0.48